Voyageur Pharmaceuticals Financial Overview
Voyageur Pharmaceuticals's market cap is currently $22.08M. The company's EPS TTM is $-0.0057190240000000005; its P/E ratio is -7.09; Voyageur Pharmaceuticals is scheduled to report earnings on October 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
